![Tanya Lewis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tanya Lewis
Direktör/Styrelseledamot på
DIAMEDICA THERAPEUTICS INC.
Förmögenhet: - $ per 2026-06-30
Profil
Tanya N.
Lewis is currently an Independent Director at DiaMedica Therapeutics, Inc. since 2023 and a Director at Sernova Biotherapeutics, Inc. Former roles include Chief Development Operations Officer at Replimune Group, Inc. from 2021 to 2024; Chief Regulatory & Quality Officer, Executive VP at Karyopharm Therapeutics, Inc. from 2019 to 2021; Vice President-Regulatory & Quality Affairs at Syros Pharmaceuticals, Inc. from 2017 to 2018; VP-Regulatory Affairs & Quality Assurance at Idera Pharmaceuticals, Inc. from 2015 to 2016; VP-Regulatory Affairs & Quality Assurance at Tesaro, Inc. from 2011 to 2015; Senior Director-Regulatory Affairs at Millennium Pharmaceuticals, Inc. in 2008; and VP-Regulatory Affairs & Quality Assurance at both Vion Pharmaceuticals, Inc. and Seaside Therapeutics LLC.
Education includes graduate studies at Massachusetts College of Pharmacy & Health Science and undergraduate studies at Northeastern University.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-05-22 | 0 ( -.--% ) | - $ | 2026-06-30 | |
| 2026-06-01 | 0 ( -.--% ) | - $ | 2026-06-30 |
Aktiva positioner av Tanya Lewis
| Företag | Position | Start |
|---|---|---|
| DIAMEDICA THERAPEUTICS INC. | Direktör/Styrelseledamot | 2023-03-01 |
| SERNOVA BIOTHERAPEUTICS INC | Direktör/Styrelseledamot | - |
Tidigare kända positioner av Tanya Lewis
| Företag | Position | Slut |
|---|---|---|
| REPLIMUNE GROUP, INC. | Direktör/Styrelseledamot | 2021-05-01 |
| KARYOPHARM THERAPEUTICS INC. | Generell Rådgivare | 2021-05-01 |
| SYROS PHARMACEUTICALS, INC. | Generell Rådgivare | 2018-07-01 |
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Generell Rådgivare | 2016-12-01 |
| TESARO INC | Generell Rådgivare | 2015-06-01 |
Tanya Lewiss utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
54
Första gradens relationer
12
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 12 |
|---|---|
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Health Technology |
Vion Pharmaceuticals, Inc.
 Vion Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops small molecule anticancer compounds | Health Technology |
Sernova Biotherapeutics, Inc.
 Sernova Biotherapeutics, Inc. BiotechnologyHealth Technology Develops life science products | Health Technology |
DiaMedica Therapeutics, Inc.
 DiaMedica Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of therapeutic treatments from novel recombinant proteins | Health Technology |
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for cancer patients | Health Technology |
Massachusetts College of Pharmacy & Health Science
 Massachusetts College of Pharmacy & Health Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seaside Therapeutics LLC
 Seaside Therapeutics LLC Medical DistributorsDistribution Services Develops drug treatments to correct or improve the course of fragile x syndrome | Distribution Services |
Karyopharm Therapeutics, Inc.
 Karyopharm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation | Health Technology |
Syros Pharmaceuticals, Inc.
 Syros Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which developing care for the frontline treatment of patients with hematologic malignancies | Health Technology |
Replimune Group, Inc.
 Replimune Group, Inc. BiotechnologyHealth Technology Develops oncolytic immunotherapies | Health Technology |
